Matches in SemOpenAlex for { <https://semopenalex.org/work/W2150564080> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2150564080 endingPage "968" @default.
- W2150564080 startingPage "962" @default.
- W2150564080 abstract "Background: Heart failure (HF) has been associated with an elevated international normalized ratio (INR) in patients on warfarin. Objectives: Compare warfarin sensitivity during hospital admission for HF exacerbation and chronic obstructive pulmonary disease (COPD) exacerbation with admissions unrelated to HF or COPD (controls) as well as during disease stability. Methods: We conducted a case-controlled observational study. Patients admitted to a tertiary teaching hospital for HF exacerbation (n = 37), COPD exacerbation (n = 26), and admissions unrelated to HF or COPD (controls, n = 60) were included. Warfarin sensitivity (INR per daily mg dose of warfarin) at admission was compared to periods of disease stability and also compared between the 3 groups. Results: The increase in warfarin sensitivity at admission was 94% for HF patients ( P < 0.0001), 59% for COPD ( P = 0.003) patients, and 24% for controls ( P = 0.002). HF patients with New York Heart Association (NYHA) class 3 and 4 and NYHA class 1 and 2 experienced changes in warfarin sensitivity of 125% ( P = 0.006) and 50% ( P = 0.13) at admission. HF patients had higher warfarin sensitivity at admission (mean = 1.62 [SD = 1.27]) compared to the control group (0.91 [0.52], P < 0.0001) and COPD group (1.03 [0.79], P = 0.04). and required greater intervention with vitamin K than controls (14% vs 0%, P = 0.007). Conclusion: HF and COPD patients were more sensitive to warfarin during disease exacerbation, with HF exacerbation having the largest impact, resulting in clinically significant management implications." @default.
- W2150564080 created "2016-06-24" @default.
- W2150564080 creator A5042291181 @default.
- W2150564080 creator A5048864074 @default.
- W2150564080 date "2015-06-23" @default.
- W2150564080 modified "2023-09-29" @default.
- W2150564080 title "Changes in Warfarin Sensitivity During Decompensated Heart Failure and Chronic Obstructive Pulmonary Disease" @default.
- W2150564080 cites W1607319963 @default.
- W2150564080 cites W1725306219 @default.
- W2150564080 cites W1978940434 @default.
- W2150564080 cites W1979506740 @default.
- W2150564080 cites W2003006226 @default.
- W2150564080 cites W2012154384 @default.
- W2150564080 cites W2042345206 @default.
- W2150564080 cites W2046753277 @default.
- W2150564080 cites W2049609209 @default.
- W2150564080 cites W2064817897 @default.
- W2150564080 cites W2076709877 @default.
- W2150564080 cites W2081514018 @default.
- W2150564080 cites W2097854437 @default.
- W2150564080 cites W2101829409 @default.
- W2150564080 cites W2110250301 @default.
- W2150564080 cites W2136489990 @default.
- W2150564080 cites W2149388786 @default.
- W2150564080 cites W2161298978 @default.
- W2150564080 cites W3058535 @default.
- W2150564080 cites W4245026440 @default.
- W2150564080 cites W4292329040 @default.
- W2150564080 doi "https://doi.org/10.1177/1060028015590438" @default.
- W2150564080 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26104049" @default.
- W2150564080 hasPublicationYear "2015" @default.
- W2150564080 type Work @default.
- W2150564080 sameAs 2150564080 @default.
- W2150564080 citedByCount "15" @default.
- W2150564080 countsByYear W21505640802016 @default.
- W2150564080 countsByYear W21505640802017 @default.
- W2150564080 countsByYear W21505640802018 @default.
- W2150564080 countsByYear W21505640802019 @default.
- W2150564080 countsByYear W21505640802020 @default.
- W2150564080 countsByYear W21505640802021 @default.
- W2150564080 countsByYear W21505640802022 @default.
- W2150564080 crossrefType "journal-article" @default.
- W2150564080 hasAuthorship W2150564080A5042291181 @default.
- W2150564080 hasAuthorship W2150564080A5048864074 @default.
- W2150564080 hasConcept C126322002 @default.
- W2150564080 hasConcept C164705383 @default.
- W2150564080 hasConcept C2776301958 @default.
- W2150564080 hasConcept C2776780178 @default.
- W2150564080 hasConcept C2777014857 @default.
- W2150564080 hasConcept C2778198053 @default.
- W2150564080 hasConcept C2779161974 @default.
- W2150564080 hasConcept C71924100 @default.
- W2150564080 hasConcept C90924648 @default.
- W2150564080 hasConceptScore W2150564080C126322002 @default.
- W2150564080 hasConceptScore W2150564080C164705383 @default.
- W2150564080 hasConceptScore W2150564080C2776301958 @default.
- W2150564080 hasConceptScore W2150564080C2776780178 @default.
- W2150564080 hasConceptScore W2150564080C2777014857 @default.
- W2150564080 hasConceptScore W2150564080C2778198053 @default.
- W2150564080 hasConceptScore W2150564080C2779161974 @default.
- W2150564080 hasConceptScore W2150564080C71924100 @default.
- W2150564080 hasConceptScore W2150564080C90924648 @default.
- W2150564080 hasIssue "9" @default.
- W2150564080 hasLocation W21505640801 @default.
- W2150564080 hasLocation W21505640802 @default.
- W2150564080 hasOpenAccess W2150564080 @default.
- W2150564080 hasPrimaryLocation W21505640801 @default.
- W2150564080 hasRelatedWork W1534309100 @default.
- W2150564080 hasRelatedWork W2016454610 @default.
- W2150564080 hasRelatedWork W2061473108 @default.
- W2150564080 hasRelatedWork W2083103840 @default.
- W2150564080 hasRelatedWork W2118269576 @default.
- W2150564080 hasRelatedWork W2168449172 @default.
- W2150564080 hasRelatedWork W2413531698 @default.
- W2150564080 hasRelatedWork W2889182102 @default.
- W2150564080 hasRelatedWork W4214878480 @default.
- W2150564080 hasRelatedWork W2151395709 @default.
- W2150564080 hasVolume "49" @default.
- W2150564080 isParatext "false" @default.
- W2150564080 isRetracted "false" @default.
- W2150564080 magId "2150564080" @default.
- W2150564080 workType "article" @default.